v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenues $ 2,941 $ 1,511 $ 5,701 $ 2,934
Operating expenses:        
Fund management and administration 1,489 1,588 2,913 2,999
Employee compensation and benefits 16,314 2,005 29,367 4,071
General and administrative expense 6,428 1,452 12,366 3,358
Marketing and advertising 79 102 195 163
Depreciation and amortization 86 54 176 106
Total operating expenses 24,396 5,201 45,017 10,697
Investment losses:        
Net unrealized loss on digital assets, at fair value (228,031) 0 (523,809) 0
Net unrealized loss on investments in preferred equity, at fair value (5,962) 0 (5,472) 0
Other investment loss (2,801) 0 (2,801) 0
Total investment losses (236,794) 0 (532,082) 0
Net operating loss (258,249) (3,690) (571,398) (7,763)
Other income/(expense):        
Other income 955 252 1,481 576
Interest expense on long-term notes payable, at fair value (40) 0 (282) 0
Change in fair value on long-term notes payable, at fair value (299) 0 (2,464) 0
Gain on extinguishment of debt 30 0 (8,431) 0
Loss on change in fair value of bitcoin held as collateral under Coinbase Loan     (2,594) 0
Transaction costs 0 (5,437) (6,525) (5,437)
Bargain purchase gain     66,704 0
Total other income/(expense) 646 (5,185) 47,889 (4,861)
Net loss before income taxes (257,603) (8,875) (523,509) (12,624)
Income tax benefit/(expense) 0 0 0 0
Net loss (257,603) (8,875) (523,509) (12,624)
Dividends on preferred stock (26,209) 0 (39,663) 0
Net loss attributable to common stockholders (283,812) (8,875) (563,172) (12,624)
Net loss attributable to common stockholders $ (283,812) $ (8,875) $ (563,172) $ (12,624)
Weighted average number of common shares outstanding:        
Basic (in shares) [1] 75,275,806 2,300,998 68,490,600 2,288,538
Diluted (in shares) [1] 75,275,806 2,300,998 68,490,600 2,288,538
Net loss per common share:        
Basic (in USD per share) [1] $ (3.77) $ (3.86) $ (8.22) $ (5.52)
Diluted (in USD per share) [1] $ (3.77) $ (3.86) $ (8.22) $ (5.52)
Investment advisory fees        
Revenues:        
Total revenues $ 1,512 $ 1,488 $ 2,859 $ 2,904
Medical device revenues        
Revenues:        
Total revenues 1,388 0 2,758 0
Other revenue        
Revenues:        
Total revenues $ 41 $ 23 $ 84 $ 30
[1] Basic and diluted earnings per common share for Class A and Class B common stock are the same.